Skip to main content
. 2003 Sep;47(9):2938–2945. doi: 10.1128/AAC.47.9.2938-2945.2003

TABLE 2.

Sequences of primers used in this study

Primer Sequence (5′→3′) Location No. as shown in Fig. 1
ISEcp1A GCAGGTCTTTTTCTGCTCC ISEcp1B transposase 1
ISEcp1B TTTCCGCAGCACCGTTTGC ISEcp1B transposase, reverse primer 2
PRECTX-M-3B CCGTTTCCGCTATTACAAAC 3′ end of blaCTX-M, reverse primer 3
PROM+ TGCTCTGTGGATAACTTGC Right part of ISEcp1B including −35 and −10 promoter sequences 4
PROM− GCAGTCTAAATTCTTCGTG Right part of ISEcp1B lacking −35 and −10 promoter sequences 5
CTX-M-REV CCGCGAACATCATCCGTTGC 5′ end of blaCTX-M-19, reverse primer for primer extension experiments 6
IS903-A CATATGAAATCATCTGCGC IS903D transposase 7
IS903-B CCGTAGCGGGTTGTGTTTTC IS903D transposase, reverse primer 8
INT2F TCTCGGGTAACATCAAGGCCC 3′ end of the int11 integrase gene 9
3′-CS AAGCAGACTTGACCTGA 5′ end of the qacEΔ1 gene, reverse primer 10
CTX-MA ACCGCGATATCGTTGGT blaCTX-M-19 gene 11
CTX-MB CGCTTTGCGATGTGCAG blaCTX-M-19 gene, reverse primer 12
ORF1B ATACTCTTGCTCATATGGGG 5′ end of ORF1 of Tn1721, reverse primer 13
HHS Vulnerability Disclosure